2017. Abnormal diastolic function underlies the different beneficial effects of cardiac resynchronization therapy on ischemic and non-ischemic cardiomyopathy. Clinics. 72, 7 (Jul. 2017), 432–437. DOI:https://doi.org/10.6061/clinics/2017(07)08.